Skip to main content
. 2020 Jan 3;19(3):1797–1805. doi: 10.3892/etm.2020.8418

Figure 2.

Figure 2.

Overexpression of miR-103a-3p results in cisplatin resistance in NSCLC cells. (A) Transfection of miR-103a-3p mimics and inhibitors significantly changed the miR-103a-3p level in A549 cells. (B) Cell viability assays revealed that overexpression of miR-103a-3p can protect A549 cells from cisplatin-induced cell death. (C) Cell viability assays revealed that overexpression of miR-103a-3p abolished cisplatin-induced inhibition of A549 cell proliferation. *P<0.05 and **P<0.01 with comparisons indicated by lines. miR, microRNA; NSCLC, non-small cell lung cancer; NC, negative control; cDDP, cisplatin.